WHO analysis: Cost of new HCV meds unaffordable globally

The cost of new medicines for patients infected with hepatitis C virus vary widely around the globe, especially when adjusted for national wealth, results from an economic analysis led by World...
Source: Hospitalist News - Category: Hospital Management Source Type: research